- Home
- GCI vs ORGO Comparison
GCI vs ORGO Comparison
Compare GCI & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GCI
- ORGO
- Stock Information
- Founded
- GCI 1997
- ORGO 1985
- Country
- GCI United States
- ORGO United States
- Employees
- GCI N/A
- ORGO N/A
- Industry
- GCI Newspapers/Magazines
- ORGO Biotechnology: Pharmaceutical Preparations
- Sector
- GCI Consumer Discretionary
- ORGO Health Care
- Exchange
- GCI Nasdaq
- ORGO Nasdaq
- Market Cap
- GCI 612.9M
- ORGO 620.3M
- IPO Year
- GCI N/A
- ORGO N/A
- Fundamental
- Price
- GCI $4.28
- ORGO $4.62
- Analyst Decision
- GCI Buy
- ORGO Buy
- Analyst Count
- GCI 3
- ORGO 2
- Target Price
- GCI $5.70
- ORGO $7.50
- AVG Volume (30 Days)
- GCI 1.2M
- ORGO 763.0K
- Earning Date
- GCI 10-30-2025
- ORGO 11-11-2025
- Dividend Yield
- GCI N/A
- ORGO N/A
- EPS Growth
- GCI N/A
- ORGO N/A
- EPS
- GCI 0.73
- ORGO N/A
- Revenue
- GCI $2,390,148,000.00
- ORGO $429,531,000.00
- Revenue This Year
- GCI N/A
- ORGO $2.57
- Revenue Next Year
- GCI N/A
- ORGO $9.80
- P/E Ratio
- GCI $6.00
- ORGO N/A
- Revenue Growth
- GCI N/A
- ORGO N/A
- 52 Week Low
- GCI $2.55
- ORGO $2.61
- 52 Week High
- GCI $5.93
- ORGO $6.71
- Technical
- Relative Strength Index (RSI)
- GCI 55.47
- ORGO 44.62
- Support Level
- GCI $4.02
- ORGO $4.75
- Resistance Level
- GCI $4.42
- ORGO $5.10
- Average True Range (ATR)
- GCI 0.14
- ORGO 0.21
- MACD
- GCI 0.01
- ORGO -0.04
- Stochastic Oscillator
- GCI 61.80
- ORGO 4.96
About GCI Gannett Co. Inc.
Gannett Co Inc is a digital newspaper company providing local media and marketing solutions in the U.S. The group operates in three segments, Domestic Gannett Media, Newsquest, and Digital Marketing Solutions. The majority of revenue is from the Domestic Gannett Media segment. The company's brands include USA TODAY and more than 250 daily newspapers as well as digital marketing services companies, including ReachLocal, WordStream, and others. The company produces more than 350 annual events, such as themed expos. The company also operates in the U.K. through the U.K. media company Newsquest, providing more than 150 local media brands.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.